Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Jørgen, Hilden"'
Autor:
Per Winkel, Janus Christian Jakobsen, Jørgen Hilden, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Christian Gluud, Kasper Karmark Iversen, Gorm Boje Jensen, Mette Bjerre
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Objective To assess if 12 novel circulating biomarkers, when added to ‘standard predictors’ available in general practice, could improve the 10-year prediction of cardiovascular events and mortality in patients with stable coronary heart disease.
Externí odkaz:
https://doaj.org/article/6b24de0522e94d5a897eb0bdd7ac0592
Autor:
Jakob Schroder, Janus Christian Jakobsen, Per Winkel, Jørgen Hilden, Gorm Boje Jensen, Ahmad Sajadieh, Anders Larsson, Johan Ärnlöv, Marina Harutyunyan, Julia S. Johansen, Erik Kjøller, Christian Gluud, Jens Kastrup
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 5 (2020)
Background The inflammatory biomarker YKL‐40 has previously been studied as a potential risk marker in cardiovascular disease. We aimed to assess the prognostic reclassification potential of serum YKL‐40 in patients with stable coronary artery di
Externí odkaz:
https://doaj.org/article/9f843d85bdcb456caaf6e47317d0da18
Autor:
Per Winkel, Janus Christian Jakobsen, Jørgen Hilden, Theis Lange, Gorm Boje Jensen, Erik Kjøller, Ahmad Sajadieh, Jens Kastrup, Hans Jørn Kolmos, Anders Larsson, Johan Ärnlöv, Christian Gluud
Publikováno v:
Diagnostic and Prognostic Research, Vol 1, Iss 1, Pp 1-8 (2017)
Abstract Background The purpose of the predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC) study is exploratory and hypothesis generating. We want to identify biochemical quantities which—conditionally on the val
Externí odkaz:
https://doaj.org/article/f08c82144fff4f30bc2bd940d8bcebb9
Autor:
Per Winkel, Janus Christian Jakobsen, Jørgen Hilden, Christian Gluud, Jørn Wetterslev, Christian Ovesen
Publikováno v:
BMJ Open, Vol 9, Iss 6 (2019)
Objective and methods: It is rare that trialists report power estimations of non-primary outcomes. In the present article, we will describe how to define a valid hierarchy of outcomes in a randomised clinical trial, to limit problems with Type I and
Externí odkaz:
https://doaj.org/article/5598c508648a4059bd8a8f94033aba7b
Publikováno v:
BMC Medical Research Methodology, Vol 16, Iss 1, Pp 1-12 (2016)
Abstract Background Blinding is a pivotal method to avoid bias in randomised clinical trials. In blinded drug trials, experimental and control interventions are often designed to be matched, i.e. to appear indistinguishable. It is unknown how often m
Externí odkaz:
https://doaj.org/article/d739de4f00d844b5bb050c03b1af5280
Autor:
Axel C. Carlsson, Toralph Ruge, Erik Kjøller, Jørgen Hilden, Hans Jørn Kolmos, Ahmad Sajadieh, Jens Kastrup, Gorm Boje Jensen, Anders Larsson, Christoph Nowak, Janus Christian Jakobsen, Per Winkel, Christian Gluud, Johan Ärnlöv
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 9 (2018)
BackgroundWe aimed to assess the associations and predictive powers between the soluble receptors for tumor necrosis factor (TNF)‐α (TNFR1 and TNFR2) and cardiovascular outcomes in patients with stable coronary heart disease. Methods and ResultsCL
Externí odkaz:
https://doaj.org/article/8042cc8ae8cb4e7f9951b5531d193fea
Publikováno v:
Jensen, E K, Bäckryd, E, Hilden, J & Werner, M U 2021, ' Trajectories in severe persistent pain after groin hernia repair : A retrospective analysis ', Scandinavian Journal of Pain, vol. 21, no. 1, pp. 70-80 . https://doi.org/10.1515/sjpain-2020-0104
Objectives Severe persistent post-surgical pain (PPSP) remains a significant healthcare problem. In the third most common surgical procedure in the U.K., groin hernia repair, including 85,000 surgeries, estimated 1,500–3,000 patients will annually
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a701e83476015986ad469a86fabd49e2
https://doi.org/10.1515/sjpain-2020-0104
https://doi.org/10.1515/sjpain-2020-0104
Autor:
Erik Kjøller, Per Winkel, Jørgen Hilden, Mette Bjerre, Johan Ärnlöv, Jens Kastrup, Jane Lindschou, Christian Gluud, Anders Larsson, Ahmad Sajadieh, Hans Jørn Kolmos, Gorm B. Jensen, Janus Christian Jakobsen
Publikováno v:
Winkel, P, Hilden, J, Jakobsen, J C, Lindschou, J, Jensen, G B, Kjøller, E, Sajadieh, A, Kastrup, J, Kolmos, H J, Larsson, A, Äarnlöv, J, Bjerre, M & Gluud, C 2021, ' A screening method to spot biomarkers that may warn of serious events in a chronic disease : Illustrated by cardiological CLARICOR trial data ', Clinical Chemistry and Laboratory Medicine, vol. 59, no. 11, pp. 1852-1860 . https://doi.org/10.1515/cclm-2021-0333
Winkel, P, Hilden, J, Jakobsen, J C, Lindschou, J, Jensen, G B, Kjøller, E, Sajadieh, A, Kastrup, J, Kolmos, H J, Larsson, A, Ärnlöv, J, Bjerre, M & Gluud, C 2021, ' A screening method to spot biomarkers that may warn of serious events in a chronic disease -illustrated by cardiological CLARICOR trial data ', Clinical Chemistry and Laboratory Medicine, vol. 59, no. 11, pp. 1852-1860 . https://doi.org/10.1515/cclm-2021-0333
Winkel, P, Hilden, J, Jakobsen, J C, Lindschou, J, Jensen, G B, Kjøller, E, Sajadieh, A, Kastrup, J, Kolmos, H J, Larsson, A, Ärnlöv, J, Bjerre, M & Gluud, C 2021, ' A screening method to spot biomarkers that may warn of serious events in a chronic disease -illustrated by cardiological CLARICOR trial data ', Clinical Chemistry and Laboratory Medicine, vol. 59, no. 11, pp. 1852-1860 . https://doi.org/10.1515/cclm-2021-0333
Objectives To develop a crude screening method for detecting biomarkers which frequently exhibit a rise (or fall) in level prior to a serious event (e.g. a stroke) in patients with a chronic disease, signalling that the biomarker may have an alarm-ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9c31a8bc52cf55c9785fc00844433a
https://portal.findresearcher.sdu.dk/da/publications/3d23e346-91e5-4c22-9f96-212a3f9e8ffc
https://portal.findresearcher.sdu.dk/da/publications/3d23e346-91e5-4c22-9f96-212a3f9e8ffc
Autor:
Ahmad Sajadieh, Erik Kjøller, Jørgen Hilden, Kasper Iversen, Hans Jørn Kolmos, Jens Kastrup, Johan Ärnlöv, Janus Christian Jakobsen, Mette Bjerre, Gorm B. Jensen, Per Winkel, Christian Gluud, Anders Larsson
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Winkel, P, Jakobsen, J C, Hilden, J, Jensen, G B, Kjøller, E, Sajadieh, A, Kastrup, J, Kolmos, H J, Iversen, K K, Bjerre, M, Larsson, A, Ärnlöv, J & Gluud, C 2020, ' Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial ', BMJ Open, vol. 10, no. 8, e033720 . https://doi.org/10.1136/bmjopen-2019-033720
Winkel, P, Jakobsen, J C, Hilden, J, Jensen, G B, Kjøller, E, Sajadieh, A, Kastrup, J, Kolmos, H J, Iversen, K K, Bjerre, M, Larsson, A, Ärnlöv, J & Gluud, C 2020, ' Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease : A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial ', BMJ Open, vol. 10, no. 8, e033720 . https://doi.org/10.1136/bmjopen-2019-033720
Winkel, P, Jakobsen, J C, Hilden, J, Jensen, G B, Kjøller, E, Sajadieh, A, Kastrup, J, Kolmos, H J, Iversen, K K, Bjerre, M, Larsson, A, Arnlöv, J & Gluud, C 2020, ' Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial ', BMJ Open, vol. 10, no. 8, e033720 . https://doi.org/10.1136/bmjopen-2019-033720
BMJ Open
Winkel, P, Jakobsen, J C, Hilden, J, Jensen, G B, Kjøller, E, Sajadieh, A, Kastrup, J, Kolmos, H J, Iversen, K K, Bjerre, M, Larsson, A, Ärnlöv, J & Gluud, C 2020, ' Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial ', BMJ Open, vol. 10, no. 8, e033720 . https://doi.org/10.1136/bmjopen-2019-033720
Winkel, P, Jakobsen, J C, Hilden, J, Jensen, G B, Kjøller, E, Sajadieh, A, Kastrup, J, Kolmos, H J, Iversen, K K, Bjerre, M, Larsson, A, Ärnlöv, J & Gluud, C 2020, ' Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease : A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial ', BMJ Open, vol. 10, no. 8, e033720 . https://doi.org/10.1136/bmjopen-2019-033720
Winkel, P, Jakobsen, J C, Hilden, J, Jensen, G B, Kjøller, E, Sajadieh, A, Kastrup, J, Kolmos, H J, Iversen, K K, Bjerre, M, Larsson, A, Arnlöv, J & Gluud, C 2020, ' Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial ', BMJ Open, vol. 10, no. 8, e033720 . https://doi.org/10.1136/bmjopen-2019-033720
BMJ Open
ObjectiveTo assess if 12 novel circulating biomarkers, when added to ‘standard predictors’ available in general practice, could improve the 10-year prediction of cardiovascular events and mortality in patients with stable coronary heart disease.D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a42f782bb4f2e56a72f9cacbff9199a
https://bmjopen.bmj.com/content/10/8/e033720.full
https://bmjopen.bmj.com/content/10/8/e033720.full
Autor:
Julia S. Johansen, Jakob Schroder, Christian Gluud, Jens Kastrup, Gorm Boje Jensen, Jørgen Hilden, Janus Christian Jakobsen, Ahmad Sajadieh, Per Winkel, Johan Ärnlöv, Anders Larsson, Marina Harutyunyan, Erik Kjøller
Publikováno v:
Schroder, J, Jakobsen, J C, Winkel, P, Hilden, J, Jensen, G B, Sajadieh, A, Larsson, A, Ärnlöv, J, Harutyunyan, M, Johansen, J S, Kjøller, E, Gluud, C & Kastrup, J 2020, ' Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease ', Journal of the American Heart Association, vol. 9, no. 5, e014634 . https://doi.org/10.1161/JAHA.119.014634
Schroder, J, Jakobsen, J C, Winkel, P, Hilden, J, Jensen, G B, Sajadieh, A, Larsson, A, Ärnlöv, J, Harutyunyan, M, Johansen, J S, Kjøller, E, Gluud, C & Kastrup, J 2020, ' Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease ', Journal of the American Heart Association, vol. 9, no. 5, e01463 . https://doi.org/10.1161/JAHA.119.014634
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Schroder, J, Jakobsen, J C, Winkel, P, Hilden, J, Jensen, G B, Sajadieh, A, Larsson, A, Ärnlöv, J, Harutyunyan, M, Johansen, J S, Kjøller, E, Gluud, C & Kastrup, J 2020, ' Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease ', Journal of the American Heart Association, vol. 9, no. 5, e01463 . https://doi.org/10.1161/JAHA.119.014634
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The inflammatory biomarker YKL‐40 has previously been studied as a potential risk marker in cardiovascular disease. We aimed to assess the prognostic reclassification potential of serum YKL‐40 in patients with stable coronary artery di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3b7b128b333e60029bdab797a4a675e
http://urn.kb.se/resolve?urn=urn:nbn:se:du-32335
http://urn.kb.se/resolve?urn=urn:nbn:se:du-32335